nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—Ketonuria—Metformin—polycystic ovary syndrome	0.0763	0.184	CcSEcCtD
Carbamazepine—Anaemia megaloblastic—Metformin—polycystic ovary syndrome	0.0305	0.0736	CcSEcCtD
Carbamazepine—Emotional distress—Metformin—polycystic ovary syndrome	0.0169	0.0408	CcSEcCtD
Carbamazepine—Appetite absent—Metformin—polycystic ovary syndrome	0.0145	0.0349	CcSEcCtD
Carbamazepine—CYP2C19—urine—polycystic ovary syndrome	0.014	0.0677	CbGeAlD
Carbamazepine—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0137	0.033	CcSEcCtD
Carbamazepine—Azotaemia—Metformin—polycystic ovary syndrome	0.0135	0.0326	CcSEcCtD
Carbamazepine—Hypothermia—Metformin—polycystic ovary syndrome	0.0128	0.0309	CcSEcCtD
Carbamazepine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0128	0.0309	CcSEcCtD
Carbamazepine—CYP1A2—urine—polycystic ovary syndrome	0.0114	0.0553	CbGeAlD
Carbamazepine—CYP2C9—urine—polycystic ovary syndrome	0.0108	0.0525	CbGeAlD
Carbamazepine—Blood disorder—Metformin—polycystic ovary syndrome	0.00862	0.0208	CcSEcCtD
Carbamazepine—CYP3A4—urine—polycystic ovary syndrome	0.00826	0.04	CbGeAlD
Carbamazepine—Accidental injury—Metformin—polycystic ovary syndrome	0.00813	0.0196	CcSEcCtD
Carbamazepine—RALBP1—adrenal cortex—polycystic ovary syndrome	0.00803	0.0389	CbGeAlD
Carbamazepine—RALBP1—endometrium—polycystic ovary syndrome	0.00717	0.0347	CbGeAlD
Carbamazepine—SCN9A—pituitary gland—polycystic ovary syndrome	0.0067	0.0325	CbGeAlD
Carbamazepine—SCN9A—adipose tissue—polycystic ovary syndrome	0.00668	0.0324	CbGeAlD
Carbamazepine—RALBP1—uterus—polycystic ovary syndrome	0.0066	0.032	CbGeAlD
Carbamazepine—RALBP1—pituitary gland—polycystic ovary syndrome	0.00649	0.0314	CbGeAlD
Carbamazepine—RALBP1—adipose tissue—polycystic ovary syndrome	0.00646	0.0313	CbGeAlD
Carbamazepine—Ear pain—Metformin—polycystic ovary syndrome	0.00612	0.0148	CcSEcCtD
Carbamazepine—SCN9A—adrenal gland—polycystic ovary syndrome	0.00599	0.029	CbGeAlD
Carbamazepine—SCN4A—pituitary gland—polycystic ovary syndrome	0.00598	0.029	CbGeAlD
Carbamazepine—SCN4A—adipose tissue—polycystic ovary syndrome	0.00596	0.0289	CbGeAlD
Carbamazepine—RALBP1—adrenal gland—polycystic ovary syndrome	0.00579	0.0281	CbGeAlD
Carbamazepine—Injury—Metformin—polycystic ovary syndrome	0.00568	0.0137	CcSEcCtD
Carbamazepine—Renal impairment—Metformin—polycystic ovary syndrome	0.00549	0.0132	CcSEcCtD
Carbamazepine—RALBP1—female gonad—polycystic ovary syndrome	0.0054	0.0262	CbGeAlD
Carbamazepine—RALBP1—vagina—polycystic ovary syndrome	0.00537	0.026	CbGeAlD
Carbamazepine—SCN4A—adrenal gland—polycystic ovary syndrome	0.00534	0.0259	CbGeAlD
Carbamazepine—Lethargy—Metformin—polycystic ovary syndrome	0.00533	0.0128	CcSEcCtD
Carbamazepine—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00518	0.0251	CbGeAlD
Carbamazepine—RALBP1—endocrine gland—polycystic ovary syndrome	0.00502	0.0243	CbGeAlD
Carbamazepine—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00502	0.0243	CbGeAlD
Carbamazepine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00482	0.0116	CcSEcCtD
Carbamazepine—Cramp muscle—Metformin—polycystic ovary syndrome	0.0047	0.0113	CcSEcCtD
Carbamazepine—Pancreatitis—Metformin—polycystic ovary syndrome	0.00443	0.0107	CcSEcCtD
Carbamazepine—Sweating increased—Metformin—polycystic ovary syndrome	0.0044	0.0106	CcSEcCtD
Carbamazepine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00433	0.0104	CcSEcCtD
Carbamazepine—Infestation—Metformin—polycystic ovary syndrome	0.00403	0.0097	CcSEcCtD
Carbamazepine—Drowsiness—Metformin—polycystic ovary syndrome	0.00403	0.0097	CcSEcCtD
Carbamazepine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00403	0.0097	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00395	0.00951	CcSEcCtD
Carbamazepine—SCN5A—vagina—polycystic ovary syndrome	0.00384	0.0186	CbGeAlD
Carbamazepine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00381	0.00918	CcSEcCtD
Carbamazepine—Bradycardia—Metformin—polycystic ovary syndrome	0.00368	0.00887	CcSEcCtD
Carbamazepine—Rhinitis—Metformin—polycystic ovary syndrome	0.00362	0.00873	CcSEcCtD
Carbamazepine—Hepatitis—Metformin—polycystic ovary syndrome	0.00361	0.00871	CcSEcCtD
Carbamazepine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00356	0.00858	CcSEcCtD
Carbamazepine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00355	0.00856	CcSEcCtD
Carbamazepine—Eye disorder—Metformin—polycystic ovary syndrome	0.00338	0.00814	CcSEcCtD
Carbamazepine—Flushing—Metformin—polycystic ovary syndrome	0.00335	0.00808	CcSEcCtD
Carbamazepine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00335	0.00808	CcSEcCtD
Carbamazepine—Angiopathy—Metformin—polycystic ovary syndrome	0.00328	0.0079	CcSEcCtD
Carbamazepine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00326	0.00787	CcSEcCtD
Carbamazepine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00326	0.00785	CcSEcCtD
Carbamazepine—Chills—Metformin—polycystic ovary syndrome	0.00324	0.00782	CcSEcCtD
Carbamazepine—Erythema—Metformin—polycystic ovary syndrome	0.00315	0.00758	CcSEcCtD
Carbamazepine—Malnutrition—Metformin—polycystic ovary syndrome	0.00315	0.00758	CcSEcCtD
Carbamazepine—ABCC2—adrenal gland—polycystic ovary syndrome	0.00311	0.0151	CbGeAlD
Carbamazepine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00308	0.00743	CcSEcCtD
Carbamazepine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00302	0.00729	CcSEcCtD
Carbamazepine—Vision blurred—Metformin—polycystic ovary syndrome	0.00296	0.00715	CcSEcCtD
Carbamazepine—Tremor—Metformin—polycystic ovary syndrome	0.00295	0.0071	CcSEcCtD
Carbamazepine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.0029	0.014	CbGeAlD
Carbamazepine—CYP2C8—endometrium—polycystic ovary syndrome	0.00288	0.014	CbGeAlD
Carbamazepine—Syncope—Metformin—polycystic ovary syndrome	0.00282	0.0068	CcSEcCtD
Carbamazepine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00276	0.00666	CcSEcCtD
Carbamazepine—Modafinil—ADRA1B—polycystic ovary syndrome	0.00272	0.142	CrCbGaD
Carbamazepine—Hypertension—Metformin—polycystic ovary syndrome	0.00272	0.00655	CcSEcCtD
Carbamazepine—ABCC2—endocrine gland—polycystic ovary syndrome	0.00269	0.0131	CbGeAlD
Carbamazepine—Chest pain—Metformin—polycystic ovary syndrome	0.00268	0.00646	CcSEcCtD
Carbamazepine—Myalgia—Metformin—polycystic ovary syndrome	0.00268	0.00646	CcSEcCtD
Carbamazepine—Epinastine—ADRA1A—polycystic ovary syndrome	0.00266	0.138	CrCbGaD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00266	0.00641	CcSEcCtD
Carbamazepine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00261	0.0126	CbGeAlD
Carbamazepine—Oedema—Metformin—polycystic ovary syndrome	0.00257	0.00619	CcSEcCtD
Carbamazepine—Infection—Metformin—polycystic ovary syndrome	0.00255	0.00615	CcSEcCtD
Carbamazepine—Shock—Metformin—polycystic ovary syndrome	0.00253	0.00609	CcSEcCtD
Carbamazepine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00252	0.00607	CcSEcCtD
Carbamazepine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00251	0.00606	CcSEcCtD
Carbamazepine—Skin disorder—Metformin—polycystic ovary syndrome	0.00249	0.00601	CcSEcCtD
Carbamazepine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00248	0.00598	CcSEcCtD
Carbamazepine—CYP2C19—vagina—polycystic ovary syndrome	0.00248	0.012	CbGeAlD
Carbamazepine—Anorexia—Metformin—polycystic ovary syndrome	0.00245	0.0059	CcSEcCtD
Carbamazepine—Hypotension—Metformin—polycystic ovary syndrome	0.0024	0.00578	CcSEcCtD
Carbamazepine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00235	0.0114	CbGeAlD
Carbamazepine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00234	0.00564	CcSEcCtD
Carbamazepine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00232	0.0112	CbGeAlD
Carbamazepine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00231	0.00556	CcSEcCtD
Carbamazepine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00229	0.00552	CcSEcCtD
Carbamazepine—Somnolence—Metformin—polycystic ovary syndrome	0.00228	0.0055	CcSEcCtD
Carbamazepine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00226	0.00545	CcSEcCtD
Carbamazepine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00223	0.00538	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00222	0.00534	CcSEcCtD
Carbamazepine—Fatigue—Metformin—polycystic ovary syndrome	0.00221	0.00534	CcSEcCtD
Carbamazepine—Constipation—Metformin—polycystic ovary syndrome	0.0022	0.00529	CcSEcCtD
Carbamazepine—CYP2C8—vagina—polycystic ovary syndrome	0.00216	0.0105	CbGeAlD
Carbamazepine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00212	0.0051	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0021	0.00506	CcSEcCtD
Carbamazepine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00209	0.0101	CbGeAlD
Carbamazepine—Urticaria—Metformin—polycystic ovary syndrome	0.00204	0.00492	CcSEcCtD
Carbamazepine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00203	0.00489	CcSEcCtD
Carbamazepine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00202	0.00979	CbGeAlD
Carbamazepine—CYP3A5—female gonad—polycystic ovary syndrome	0.00196	0.00951	CbGeAlD
Carbamazepine—CYP3A5—vagina—polycystic ovary syndrome	0.00195	0.00945	CbGeAlD
Carbamazepine—CYP2B6—vagina—polycystic ovary syndrome	0.00194	0.00939	CbGeAlD
Carbamazepine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.00193	0.1	CrCbGaD
Carbamazepine—Promazine—ADRA1D—polycystic ovary syndrome	0.00191	0.0994	CrCbGaD
Carbamazepine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00189	0.00917	CbGeAlD
Carbamazepine—ABCB1—embryo—polycystic ovary syndrome	0.00189	0.00916	CbGeAlD
Carbamazepine—Asthenia—Metformin—polycystic ovary syndrome	0.00184	0.00444	CcSEcCtD
Carbamazepine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00182	0.00884	CbGeAlD
Carbamazepine—Pruritus—Metformin—polycystic ovary syndrome	0.00182	0.00438	CcSEcCtD
Carbamazepine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00181	0.00879	CbGeAlD
Carbamazepine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.0018	0.0087	CbGeAlD
Carbamazepine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00176	0.00423	CcSEcCtD
Carbamazepine—Dizziness—Metformin—polycystic ovary syndrome	0.0017	0.00409	CcSEcCtD
Carbamazepine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00167	0.087	CrCbGaD
Carbamazepine—Vomiting—Metformin—polycystic ovary syndrome	0.00163	0.00393	CcSEcCtD
Carbamazepine—Promazine—ADRA1B—polycystic ovary syndrome	0.00163	0.0848	CrCbGaD
Carbamazepine—Rash—Metformin—polycystic ovary syndrome	0.00162	0.0039	CcSEcCtD
Carbamazepine—Dermatitis—Metformin—polycystic ovary syndrome	0.00162	0.0039	CcSEcCtD
Carbamazepine—Headache—Metformin—polycystic ovary syndrome	0.00161	0.00388	CcSEcCtD
Carbamazepine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00155	0.0075	CbGeAlD
Carbamazepine—Nausea—Metformin—polycystic ovary syndrome	0.00153	0.00368	CcSEcCtD
Carbamazepine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00143	0.0743	CrCbGaD
Carbamazepine—ABCB1—endometrium—polycystic ovary syndrome	0.00138	0.0067	CbGeAlD
Carbamazepine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00137	0.00663	CbGeAlD
Carbamazepine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.0013	0.0674	CrCbGaD
Carbamazepine—ABCB1—uterus—polycystic ovary syndrome	0.00127	0.00617	CbGeAlD
Carbamazepine—ABCB1—pituitary gland—polycystic ovary syndrome	0.00125	0.00606	CbGeAlD
Carbamazepine—Promethazine—ADRA1A—polycystic ovary syndrome	0.00125	0.0649	CrCbGaD
Carbamazepine—ABCB1—adipose tissue—polycystic ovary syndrome	0.00125	0.00604	CbGeAlD
Carbamazepine—ABCB1—adrenal gland—polycystic ovary syndrome	0.00112	0.00542	CbGeAlD
Carbamazepine—Promazine—ADRA1A—polycystic ovary syndrome	0.0011	0.0571	CrCbGaD
Carbamazepine—ABCB1—female gonad—polycystic ovary syndrome	0.00104	0.00505	CbGeAlD
Carbamazepine—ABCB1—vagina—polycystic ovary syndrome	0.00104	0.00502	CbGeAlD
Carbamazepine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000969	0.0047	CbGeAlD
Carbamazepine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000961	0.05	CrCbGaD
Carbamazepine—Desipramine—ADRB2—polycystic ovary syndrome	0.000674	0.0351	CrCbGaD
Carbamazepine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	7.98e-05	0.000222	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.89e-05	0.000219	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	7.88e-05	0.000219	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.86e-05	0.000219	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	7.83e-05	0.000218	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.82e-05	0.000217	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	7.72e-05	0.000215	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	7.69e-05	0.000214	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	7.63e-05	0.000212	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.6e-05	0.000211	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	7.47e-05	0.000208	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.46e-05	0.000207	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	7.33e-05	0.000204	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	7.32e-05	0.000204	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	7.32e-05	0.000204	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	7.31e-05	0.000203	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	7.29e-05	0.000203	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	7.2e-05	0.0002	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	7.18e-05	0.0002	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	7.15e-05	0.000199	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	7.15e-05	0.000199	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	7.14e-05	0.000199	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	7.14e-05	0.000199	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	7.12e-05	0.000198	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.12e-05	0.000198	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	7.11e-05	0.000198	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	7.09e-05	0.000197	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.04e-05	0.000196	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.04e-05	0.000196	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	6.98e-05	0.000194	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	6.98e-05	0.000194	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	6.95e-05	0.000193	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.95e-05	0.000193	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.93e-05	0.000193	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	6.92e-05	0.000192	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	6.81e-05	0.000189	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	6.79e-05	0.000189	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	6.76e-05	0.000188	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.71e-05	0.000187	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.65e-05	0.000185	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.63e-05	0.000184	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	6.62e-05	0.000184	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	6.5e-05	0.000181	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.42e-05	0.000179	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	6.37e-05	0.000177	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.36e-05	0.000177	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	6.35e-05	0.000177	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	6.22e-05	0.000173	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.21e-05	0.000173	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	6.2e-05	0.000172	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	6.19e-05	0.000172	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	6.17e-05	0.000172	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	6.17e-05	0.000172	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.14e-05	0.000171	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TH—polycystic ovary syndrome	6.14e-05	0.000171	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	6.08e-05	0.000169	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	6.06e-05	0.000168	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	6.05e-05	0.000168	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	6.03e-05	0.000168	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.99e-05	0.000167	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	5.97e-05	0.000166	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	5.94e-05	0.000165	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	5.91e-05	0.000164	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	5.86e-05	0.000163	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.83e-05	0.000162	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	5.82e-05	0.000162	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	5.81e-05	0.000162	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	5.79e-05	0.000161	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	5.71e-05	0.000159	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.68e-05	0.000158	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.65e-05	0.000157	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.65e-05	0.000157	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	5.64e-05	0.000157	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	5.61e-05	0.000156	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	5.58e-05	0.000155	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	5.55e-05	0.000154	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	5.52e-05	0.000154	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	5.52e-05	0.000154	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	5.51e-05	0.000153	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.49e-05	0.000153	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.46e-05	0.000152	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	5.4e-05	0.00015	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	5.39e-05	0.00015	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	5.39e-05	0.00015	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	5.33e-05	0.000148	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	5.27e-05	0.000147	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	5.24e-05	0.000146	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	5.23e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	5.22e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	5.21e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.18e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.13e-05	0.000143	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.1e-05	0.000142	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.04e-05	0.00014	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.03e-05	0.00014	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	5.01e-05	0.000139	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	5e-05	0.000139	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	4.95e-05	0.000138	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	4.93e-05	0.000137	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL6—polycystic ovary syndrome	4.92e-05	0.000137	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	4.92e-05	0.000137	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—INS—polycystic ovary syndrome	4.91e-05	0.000136	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	4.84e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	4.81e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.81e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	4.78e-05	0.000133	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	4.77e-05	0.000133	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	4.77e-05	0.000133	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.74e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.74e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	4.72e-05	0.000131	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	4.7e-05	0.000131	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.67e-05	0.00013	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	4.66e-05	0.00013	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	4.55e-05	0.000127	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	4.54e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	4.52e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	4.51e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	4.49e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.49e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	4.44e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	4.43e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.42e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	4.41e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.39e-05	0.000122	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.38e-05	0.000122	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.32e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.31e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	4.3e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.29e-05	0.000119	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.28e-05	0.000119	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.26e-05	0.000119	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.25e-05	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.23e-05	0.000118	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	4.22e-05	0.000117	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.21e-05	0.000117	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.21e-05	0.000117	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.16e-05	0.000116	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	4.15e-05	0.000115	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.1e-05	0.000114	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.07e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.06e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.03e-05	0.000112	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	3.96e-05	0.00011	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	3.94e-05	0.000109	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.93e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.91e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	3.89e-05	0.000108	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.87e-05	0.000108	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.86e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	3.84e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.82e-05	0.000106	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	3.75e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	3.74e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	3.7e-05	0.000103	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	3.67e-05	0.000102	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.64e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	3.63e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	3.62e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	3.61e-05	0.0001	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	3.53e-05	9.81e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	3.51e-05	9.77e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	3.5e-05	9.74e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.45e-05	9.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.43e-05	9.54e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	3.42e-05	9.51e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	3.37e-05	9.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.36e-05	9.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—INS—polycystic ovary syndrome	3.35e-05	9.33e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.35e-05	9.31e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	3.34e-05	9.3e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.34e-05	9.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.34e-05	9.28e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.32e-05	9.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.32e-05	9.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.3e-05	9.17e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.27e-05	9.09e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.26e-05	9.05e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.25e-05	9.03e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.14e-05	8.75e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.14e-05	8.72e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.14e-05	8.72e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.14e-05	8.72e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.13e-05	8.7e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	3.12e-05	8.67e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.09e-05	8.59e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.06e-05	8.51e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.05e-05	8.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.04e-05	8.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	2.99e-05	8.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.89e-05	8.05e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.86e-05	7.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	2.83e-05	7.88e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.8e-05	7.79e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	2.8e-05	7.79e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.73e-05	7.6e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.7e-05	7.51e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.67e-05	7.43e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.67e-05	7.42e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.64e-05	7.34e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.6e-05	7.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.6e-05	7.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.6e-05	7.22e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.56e-05	7.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.55e-05	7.1e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	2.53e-05	7.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.53e-05	7.03e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	2.49e-05	6.94e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	2.48e-05	6.9e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.47e-05	6.87e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.47e-05	6.86e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.44e-05	6.8e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.44e-05	6.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.43e-05	6.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.42e-05	6.74e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.42e-05	6.73e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.38e-05	6.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.36e-05	6.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.3e-05	6.41e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.3e-05	6.4e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.18e-05	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.15e-05	5.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.14e-05	5.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.11e-05	5.87e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.1e-05	5.84e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.08e-05	5.78e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.06e-05	5.73e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.01e-05	5.58e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.97e-05	5.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.91e-05	5.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.89e-05	5.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.88e-05	5.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.87e-05	5.21e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.87e-05	5.19e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.84e-05	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.84e-05	5.11e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.83e-05	5.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.74e-05	4.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.72e-05	4.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.71e-05	4.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.68e-05	4.68e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.6e-05	4.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	4.23e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.49e-05	4.14e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.47e-05	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.46e-05	4.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	3.94e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	3.2e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.13e-05	3.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.13e-05	3.13e-05	CbGpPWpGaD
